Table 4 Pathology concordance of biopsy schemes and radical prostatectomy specimen final pathology
| Â | Radical prostatectomy specimens (GG) | Â | |||
|---|---|---|---|---|---|
biopsy specimens | 1 | 2 | 3 | 4 | 5 |
SB (n = 104) | 0 | 33 (32%) | 36 (35%) | 13 (12%) | 22 (21%) |
GG1 (n = 14) | 0 | 7 (6.7%) | 7 (6.7%) | 0 | 0 |
GG2 (n = 14) | 0 | 7 (6.7%) | 4 (3.8%) | 0 | 3 (2.9%) |
GG3 (n = 29) | 0 | 11 (11%) | 9 (8.7%) | 5 (4.8%) | 4 (3.8%) |
GG4 (n = 24) | 0 | 5 (4.8%) | 8 (7.7%) | 6 (5.8%) | 5 (4.8%) |
GG5 (n = 23) | 0 | 3 (2.9%) | 8 (7.7%) | 2 (1.9%) | 10 (9.6%) |
TB (n = 107) | 0 | 37 (35%) | 33 (31%) | 13 (12%) | 24 (22%) |
GG1 (n = 2) | 0 | 1 (0.9%) | 0 | 0 | 1 (0.9%) |
GG2 (n = 28) | 0 | 21 (20%) | 7 (6.5%) | 0 | 0 |
GG3 (n = 31) | 0 | 8 (7.5%) | 16 (15%) | 4 (3.7%) | 3 (2.8%) |
GG4 (n = 27) | 0 | 5 (4.7%) | 6 (5.6%) | 7 (6.5%) | 9 (8.4%) |
GG5 (n = 19) | 0 | 2 (1.9%) | 4 (3.7%) | 2 (1.9%) | 11 (10%) |
SB + TB (n = 113) | 0 | 39 (34%) | 37 (33%) | 13 (12%) | 24 (21%) |
GG1 (n = 0) | 0 | 2 (1.8%) | 1 (0.9%) | 0 | 0 |
GG2 (n = 7) | 0 | 14 (12%) | 4 (3.5%) | 0 | 0 |
GG3 (n = 13) | 0 | 12 (11%) | 13 (12%) | 2 (1.8%) | 1 (0/9%) |
GG4 (n = 23) | 0 | 9 (8.0%) | 10 (8.8%) | 8 (7.1%) | 5 (4.4%) |
GG5 (n = 26) | 0 | 2 (1.8%) | 9 (8.0%) | 3 (1.7%) | 18 (16%) |